BioSpace

SEPTEMBER 26, 2023

The COVID-19 pandemic highlighted a need for local production of vaccines. Now, German pharma company BioNTech has said it will start manufacturing vaccines in Africa.

Manufacturing 118

Manufacturing Vaccination Vaccine Pharma Companies 118

World of DTC Marketing

JULY 22, 2020

QUICK READ : The government is agreeing to pay billions of dollars to the first company that developed a COVID-19 vaccine. billion for 100 million doses of a vaccine made by Pfizer Inc. The question that the media is asking is “will consumers trust a COVID-19 vaccine?” health officials agreed to pay $1.95

Vaccination 130

Vaccination Vaccine Pharma Companies Development 130

pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . It is really important and we have seen a lot of pharma companies interested in the UK. Speed is everything in clinical development.

Vaccination 141

Vaccination Vaccine Manufacturing Clinical Development 141

World of DTC Marketing

NOVEMBER 27, 2020

SUMMARY: Business by press release has made pharma executives a lot of money but we still haven’t seen any over reviewed data on COVID 19 vaccines. The American Nurses Association, a national professional organization, said one-third of its members do not intend to take the vaccine, and an additional third are undecided.

Vaccine 208

Vaccine Vaccination Pharma Companies Trials 208

pharmaphorum

AUGUST 1, 2024

Valneva has bolstered its vaccines pipeline with a shot designed to protect against shigellosis – a major global health threat – licensed from LimmaTech Biologics.The French pharma company – best known for its COVID-19 jab and recent approval for the world's first chikungunya vaccine Ixchiq – is paying €10 million upfront for a stake in LimmaTech's (..)

Vaccination 105

Vaccination Vaccine Pharma Companies Licensing 105

BioSpace

OCTOBER 28, 2020

BioSpace provides an up-to-date overview of these deals and the projected COVID-19 vaccine doses each company plans to have within the next couple of years.

Pharma Companies 92

Pharma Companies Vaccination Vaccine 92

Pharmaceutical Technology

JANUARY 16, 2023

Recent cases in the pharmaceutical sector include Poolbeg Pharma finding more than one respiratory syncytial virus (RSV) vaccine candidate with AI by going through a vast amount of early stage clinical data to prioritise candidates and reposition them as novel treatments for RSV infection.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.

Vaccination 134

Vaccination Vaccine Clinical Trials Clinical Trials 134

BioSpace

APRIL 18, 2024

French healthcare and pharma company Sanofi will terminate an undisclosed number of positions in its U.S. vaccines commercial unit in an effort to streamline the strategic sales structure.

Vaccination 96

Vaccination Vaccine Pharma Companies Sales 96

World of DTC Marketing

APRIL 20, 2021

With medical visits picking up again among patients vaccinated against covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments. Pfizer could sell $24 billion in Covid Vaccine this year.

Vaccine 253

Vaccine Vaccination Doctors Doctor 253

pharmaphorum

MARCH 24, 2021

The Prime Minister reportedly told Conservative backbench MPs on a Zoom call that “capitalism” and “greed” was behind the success of the UK’s COVID-19 vaccination programme, before backtracking after realising he had made a blunder and telling attendees to forget the comments. " But he’s wrong.

Vaccination 124

Vaccination Vaccine Pharma Companies Doctors 124

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. Meanwhile, China and Russia have rolled out state-owned vaccines. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year.

Sales 137

Sales Vaccination Vaccine Marketing 137

BioPharma Reporter

MARCH 23, 2021

The pharma company and the CDC are recommending that adults continue routine vaccination during the COVID-19 pandemic to reduce future vaccine-preventable disease (VPD) outbreaks and overall strain on the healthcare system.

Vaccination 98

Vaccination Vaccine Pharma Companies Regulation 98

pharmaphorum

NOVEMBER 13, 2020

Hungary is to order a consignment of Russia’s Sputnik V COVID-19 vaccine, as the country struggles to contain the infection rate. According to press reports , the decision puts Hungary on “collision course” with the EU, which has not approved the vaccine or plans to review it either. The country has had more than 1.8

Vaccination 115

Vaccination Vaccine Pharma Companies Containment 115

World of DTC Marketing

APRIL 21, 2021

The amount of money Pfizer is going to make from their vaccine borders on obscene while PBMs quietly take a cut of every Rx transaction without really adding any value. ” J&J has had problems in the past, but they’re trying to be an ethical and responsible pharma company. Pharma is a big business.

Vaccination 273

Vaccination Vaccine Pharmacy Pharma Companies 273

World of DTC Marketing

SEPTEMBER 23, 2021

SUMMARY: Pfizer will earn over 26 billion dollars from their COVID vaccine, while Moderna and J&J also look to their vaccines for more profit dollars. Here is his rationale: “ When we asked the Pfizer colleagues to develop a Covid-19 vaccine in l ess than a year, you did. trillion social spending package.

Vaccine 214

Vaccine Vaccination Drugs Packaging 214

pharmaphorum

NOVEMBER 29, 2021

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccination 105

Vaccination Vaccine Manufacturing Pharma Companies 105

Pharmaceutical Technology

AUGUST 30, 2022

Only a limited number of international pharma companies, however, operate manufacturing sites in the country. Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America.

Manufacturing 195

Manufacturing Marketing Pharma Companies Vaccination 195

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .

Packaging 130

Packaging Packaging Vaccination Vaccine 130

World of DTC Marketing

AUGUST 9, 2021

86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. Doximity was flagged for having anti-vaccine information. HCPs don’t necessarily want pharma trying to sell products via social media.

Nurses 294

Nurses Marketing Pharma Companies Production 294

pharmaphorum

OCTOBER 7, 2021

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

Medical Xpress

MARCH 13, 2023

Six mobile vaccine production units by German pharma company BioNTech arrived in Rwanda on Monday, the first such shipments to Africa as the continent seeks to boost mRNA vaccine manufacturing.

Vaccination 75

Vaccination Vaccine Pharma Companies Manufacturing 75

BioPharma Reporter

NOVEMBER 18, 2020

While governments are now getting ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine, concern about vaccine hesitancy is growing worldwide. The COVID-19 pandemic is expected to continue to impose enormous burdens on societies and economies globally.

Pharma Companies 59

Pharma Companies Vaccination Vaccine Regulation 59

pharmaphorum

AUGUST 23, 2021

The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. Proponents of the approach claim that DNA vaccines may have advantages over other technologies like mRNA.

DNA 98

DNA Vaccination Vaccine Genetic Engineering 98

pharmaphorum

SEPTEMBER 20, 2022

Ben Hargreaves highlights the innovation in vaccine delivery that could make a difference in providing low- and middle-income countries with vaccination options, as well as offer a boost to programs in higher-income countries. The question to be answered in the future will be how to improve upon existing vaccine technology.

Vaccination 98

Vaccination Vaccine Immune Response Antibody 98

Pharmaceutical Technology

AUGUST 1, 2022

Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

BioPharma Reporter

FEBRUARY 2, 2021

Rows about vaccine supply and threats of export blocks donât do anything to bring us closer to ending the COVID-19 pandemic, say campaigners pushing for vaccine equity on a global level.

Pharma Companies 65

Pharma Companies Vaccination Vaccine Regulation 65

World of DTC Marketing

AUGUST 13, 2020

IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. Yet, too many pharma companies don’t get social media snapshots of what’s being said.

Branding 223

Branding Pharma Companies Doctors Doctor 223

World of DTC Marketing

JANUARY 7, 2021

Some within pharma has worked at so many jobs their resume reads like a list of pharma companies. These people tend to want titles of importance and come across as someone who would politically fit within a company. Why hasn’t Pfizer offered some help in vaccine distribution?

Pharma Companies 215

Pharma Companies HR Vaccination Vaccine 215

World of DTC Marketing

MARCH 11, 2022

3hree: Those with higher levels of trust in healthcare are more likely to be proactive about their general health, vaccinated against COVID-19, supportive of public health measures over personal freedom, and accepting of changing recommendations from healthcare officials than are low-trusting respondents.

Pharma Companies 212

Pharma Companies Vaccination Vaccine Drugs 212

XTalks

SEPTEMBER 5, 2023

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

World of DTC Marketing

FEBRUARY 4, 2021

Misuse Federal Data to Falsely Claim COVID Vaccines Are Dangerous. The national vaccine safety surveillance program run by the Centers for Disease Control and Prevention (CDC) and the U.S. Established anti-vaccine activists and groups are newly interested in mining VAERS data to suggest that matters are even worse than what it shows.

Vaccine 180

Vaccine Vaccination HR Packaging 180

World of DTC Marketing

NOVEMBER 24, 2020

Pfizer’s ad in newspapers yesterday was a good start to trying to earn back trust but unfortunately the misinformation about vaccine candidates is already starting to gather momentum. Pharma companies have a major opportunity to earn back the trust of a skeptical public but it’s going to take a consistent effort.

Scientist 277

Scientist Pharma Companies Production Sales 277

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccination 96

Vaccination Vaccine Production Licensing 96

World of DTC Marketing

MARCH 1, 2021

Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. The employees at J&J are saying, on LinkedIn, how proud they are that their company developed a COVID vaccine. More support and improvement of processes are needed.

Vaccine 180

Vaccine Vaccination Pharma Companies Drugs 180

The Pharma Data

DECEMBER 20, 2020

UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Vaccination 52

World of DTC Marketing

FEBRUARY 21, 2022

Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs.

Regulation 218

Regulation Drugs Bioequivalency Vaccination 218